For instance, while TGF-β was present in the healthy control and those with NAFLD or HCC, its interaction with the activating receptors Tgfbr1/Tgfbr2 and modulatory receptors Acvr1b/Tgfbr241 was present only in the Ctrl group. This evidence concerns the gene ACVR1B and hepatocellular carcinoma.